date,title,source
Oct-17-18,Novartis Q3 Earnings Preview,Benzinga
Oct-18-18,[$$] Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion,The Wall Street Journal
Oct-18-18,Endocyte's $2.1 Billion Deal Rewards Investors Who Stuck It Out,Bloomberg
Oct-18-18,Novartis to Buy Biopharmaceutical Company Endocyte for $2.1 Billion,GuruFocus.com
Oct-18-18,This tiny biotech spun a quick $2 billion from $12 million,MarketWatch
Oct-18-18,FDA snubs Novartis bid to repurpose inflammation drug for heart attacks,Reuters
Oct-18-18,Novartis Reports Positive Long-Term Data From Cosentyx Trials,Zacks
Oct-18-18,Novartis Gets Key Therapy -- For Almost 200 Times Its Last Price,Bloomberg
Oct-18-18,"Why Endocyte, Inc. Stock Is Soaring Today",Motley Fool
Oct-18-18,Novartis Secures Prostate Cancer Treatment With Endocyte Deal,TheStreet.com
Oct-18-18,Novartis To Buy Endocyte In $2.1B Deal,Benzinga
Oct-18-18,[$$] Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion,The Wall Street Journal
Oct-18-18,"The Daily Biotech Pulse: Novartis Buys Endocyte, Proteostasis Positive Cystic Fibrosis Trial, 2 IPOs",Benzinga
Oct-18-18,Endocyte stock pops 50% on $2.1 bln Novartis acquisition,MarketWatch
Oct-18-18,[$$] European Equities Market Talk Roundup,The Wall Street Journal
Oct-18-18,Novartis pushes deeper into nuclear medicine with $2.1 billion deal,Reuters
Oct-18-18,Novartis: 3Q Earnings Snapshot,Associated Press
Oct-18-18,Novartis pushes deeper into nuclear medicine with $2.1 bln deal,Reuters
Oct-18-18,[$$] European Corporate News Roundup,The Wall Street Journal
Oct-18-18,Endocyte Enters Into Agreement to be Acquired by Novartis for $24/Share,Benzinga
Oct-18-18,Novartis to buy cancer drugmaker Endocyte for $2.1 billion in cash,Reuters
Oct-18-18,Novartis to buy cancer drugmaker Endocyte for $2.1 billion in cash,Reuters
Oct-18-18,Novartis to buy cancer drugmaker Endocyte for $2.1 bln in cash,Reuters
Oct-18-18,"Novartis raises 2018 sales outlook as Entresto, Cosentyx accelerate",Reuters
Oct-18-18,Novartis to buy Endocyte for $2.1 billion in cash,Reuters
Oct-18-18,Novartis CEO: No fundamental changes to operations from B...,CNBC Videos
Oct-19-18,"The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut",Benzinga
Oct-19-18,Today's Research Reports on Trending Tickers: Pfizer and Novartis,ACCESSWIRE
Oct-19-18,This tiny biotech spun a quick $2 billion from $12 million,MarketWatch
Oct-22-18,"Novartis (NVS) Q3 Earnings In Line, Revenues Beat Estimates",Zacks
Oct-22-18,"BIIB, ALKS Q3 Earnings Due on Oct 23: What's in Store?",Zacks
Oct-22-18,This tiny biotech spun a quick $2 billion from $12 million,MarketWatch
Oct-23-18,"Biotech Stocks Earnings Lineup for Oct 24: VRTX, ALXN & SRPT",Zacks
Oct-25-18,"Bulls bet this financial name is set to bounce. Plus, the...",CNBC Videos
Oct-26-18,"Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO",Zacks
Oct-26-18,"The Daily Biotech Pulse: Gilead's Q2, Syndax Breast Cancer Drug Setback, Synergy Pharma On Brink Of Default",Benzinga
Oct-29-18,Drugmakers tout new medicines as eye disease battle intensifies,Reuters
Oct-29-18,"Novartis, Pfizer join forces on potentially lucrative fatty liver disease",Reuters
Oct-30-18,Aging Blockbusters Send Amgen Inc.'s Bottom Line Lower,Motley Fool
Oct-30-18,Incyte Corp (INCY) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-31-18,GlaxoSmithKline plc (GSK) Q3 Earnings Conference Call Transcript,Motley Fool
Oct-31-18,Premier Bay Area biotech developer tees up next major project,American City Business Journals
Oct-31-18,"Aduro (ADRO) Q3 Loss Narrower Than Expected, Revenues Lag",Zacks
Oct-31-18,FDA approves Novartis' copy of AbbVie bestseller Humira,Reuters
Oct-31-18,"Amgen (AMGN) Beats on Earnings & Sales in Q3, Raises View",Zacks
Oct-31-18,"Glaxo (GSK) Beats Earnings Estimates in Q3, Revenue In-line",Zacks
Nov-01-18,Gene therapy: CHOP unveils $75M manufacturing facility (Photos),American City Business Journals
Nov-02-18,Novartis abandons effort for U.S. approval of biosimilar rituximab,Reuters
Nov-02-18,Novartis data at ASH and SABCS show strength of pipeline and portfolio in hematology and oncology,PR Newswire
Nov-02-18,"Conatus' (CNAT) Q3 Loss In Line, Revenues Lag Estimates",Zacks
Nov-05-18,"4 months after drug approval, Achaogen eyes fire sale",American City Business Journals
Nov-06-18,"Ionis Pharmaceuticals, Inc. (IONS) Q3 2018 Earnings Conference Call Transcript",Motley Fool
Nov-06-18,What Lies in Store for Ligand (LGND) This Earnings Season?,Zacks
Nov-07-18,This Rockville biotech is expanding to a new HQ. Here are the details.,American City Business Journals
Nov-07-18,Amgen (AMGN) Counts on New Drugs Amid Rising Biosimilar Woes,Zacks
Nov-08-18,Novartis division Sandoz recalls one lot of blood pressure drug,Reuters
Nov-08-18,Ligand Pharmaceuticals Inc (LGND) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Nov-09-18,"Ligand (LGND) Beats on Q3 Earnings & Revenues, Raises View",Zacks
Nov-12-18,Tilray (TLRY) to Report Q3 Earnings: What's in the Cards?,Zacks
Nov-12-18,These Biopharmas Could Cure Genetic Diseases  At $5 Million Apiece,Investor's Business Daily
Nov-14-18,Migraine-Focused Biotech Has A Headache On Quarterly Losses,Investor's Business Daily
Nov-14-18,Novartis AG (NVS) Not Doing Enough to Attract Smart Money,Insider Monkey
Nov-15-18,Novartis launches third-to-market Remicade copy in Germany,Reuters
Nov-15-18,"The Zacks Analyst Blog Highlights: Chevron, Novartis, Qualcomm, TJX and Deere",Zacks
Nov-15-18,"Novartis 'completely committed' to Sandoz, has no split-off plan",Reuters
Nov-15-18,"Novartis says 'completely committed' to Sandoz, not planning split-off",Reuters
Nov-16-18,Novartis' blood disorder drug gets FDA approval for expanded use,Reuters
Nov-16-18,Alphabet unit halts glucose-detecting contact lens project,Reuters
Nov-19-18,[$$] Novartis CEO Bets on Cutting-Edge Science to Remake Drug Giant,The Wall Street Journal
Nov-20-18,Gilead's Vemlidy Gets Approval in China for HBV Infection,Zacks
Nov-20-18,CYRX: Q3 Another Very Strong Quarter With New Records in Several Categories. Operating Leverage Continues To Solidify,Zacks Small Cap Research
Nov-20-18,"The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings",Benzinga
Nov-21-18,This Highly Rated Pharma Giant Is More Than Just A Diabetes Player,Investor's Business Daily
Nov-23-18,US benefits manager baulks after Novartis values gene therapy at $4-5 mln,Reuters
Nov-23-18,"Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs",Zacks
Nov-23-18,Novartis's pricing might be tested with costly eye therapy,Reuters
Nov-23-18,Novartis Gets Approval for Gene Therapy Luxturna in Europe,Zacks
Nov-23-18,U.S. benefits manager baulks after Novartis values gene therapy at $4-5 million,Reuters
Nov-26-18,Spark Therapeutics' Luxturna Gets EU Approval for Vision Loss,Zacks
Nov-26-18,"Health Care Digest: Genentech's blood cancer win, a boost for Gilead's HIV PrEP and a tiny IPO swings at antibiotics",American City Business Journals
Nov-26-18,Novartis CEO: 4 factors can help the industry price and pay for lifesaving cell and gene therapies,CNBC
Nov-26-18,4 Reasons Why Lilly is Up More Than 30% This Year So Far,Zacks
Nov-26-18,European approval of Spark Therapeutics' gene therapy triggers $25M payment,American City Business Journals
Nov-27-18,Roche buys U.S. biotech Jecure in race for liver disease drugs,Reuters
Nov-27-18,Novartis's Alcon sees myopia epidemic driving sales growth,Reuters
Nov-27-18,3 Reasons Why Glaxo (GSK) Stock is Up This Year So Far,Zacks
Nov-28-18,Novartis (NVS) Receives EC Approval for Neulasta Biosimilar,Zacks
Nov-28-18,Celgene & Bluebird's CAR T Therapy Study Completes Enrollment,Zacks
Nov-28-18,Novartis' Biosimilar to Amgen's Neulasta Approved in Europe,GuruFocus.com
Nov-28-18,Novartis joins rush of science companies moving to White City,Evening Standard
Nov-28-18,"Glaxo's Horlicks Sale Bid Heats Up, Nestle, Unilever Close In",Zacks
Nov-29-18,Teva's Rituxan Biosimilar Gets FDA Nod in Non-Hodgkin Lymphoma,Zacks
Nov-29-18,Roche (RHHBY) to Acquire Jecure and Enter the NASH Space,Zacks
Nov-29-18,4 Big Pharma Stocks to Add to Your Portfolio in December,Zacks
Nov-30-18,Pfizer Stock Edges Into Buy Zone On AbbVie Deal For Humira Biosimilar,Investor's Business Daily
Nov-30-18,This Biotech Stock Could Launch Its First CRISPR Drug In 2022,Investor's Business Daily
Nov-30-18,Novartis' Gilenya Approved in EU for Expanded Population,Zacks
Nov-30-18,Novartis CEO Has One New Breakthrough Drug: It Costs $4 Million,Meredith Videos
Dec-03-18,UPDATE 1-High-cost Gilead cell therapy proves durable for some lymphoma patients,Reuters
Dec-03-18,Novartis SMA treatment could get FDA approval in May,Reuters
Dec-04-18,Incyte (INCY) Announces Positive Data on Jakafi for GVHD,Zacks
Dec-04-18,Gilead (GILD) Announces Data on CAR T Therapy Candidate,Zacks
Dec-04-18,FDA Accepts BLA & Gives Priority Review to Novartis' AVXS-101,Zacks
Dec-04-18,Global Blood Therapeutics' Voxelotor on Faster Approval Path,Zacks
Dec-04-18,Glaxo to Sell India's Popular Horlicks Brand to Unilever,Zacks
Dec-04-18,Novartis's new treatment for hives outperforms Xolair in trials,Reuters
Dec-06-18,Novartis to launch Adamis' EpiPen rival in U.S. next year,Reuters
Dec-06-18,Conatus' Emricasan Misses Primary Endpoint in Mid-Stage Study,Zacks
Dec-06-18,Roche's Kadcyla Halves Death Risk in Breast Cancer Study,Zacks
Dec-10-18,"Amgen (AMGN) Continues to Reward Shareholders, Ups Dividend",Zacks
Dec-11-18,Teva (TEVA) Stock Poised to Record Big Gains in 2019?,Zacks
Dec-11-18,"The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings",Benzinga
Dec-12-18,J&J says its psoriasis drug superior to Novartis treatment in study,Reuters
Dec-12-18,J&J says its psoriasis drug superior to Novartis' in study,Reuters
Dec-13-18,J&J's Tremfya Beats Novartis' Cosentyx in Head-to-Head Study,Zacks
Dec-13-18,"The Daily Biotech Pulse: Vivus Extends Supply Deal With Sandoz, Applied Genetic Snaps Ties With Biogen",Benzinga
Dec-14-18,Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?,Zacks
Dec-14-18,"Pharma Stock Roundup: AZN, RHHBY Cancer Drugs, LLY, BMY New Deals in Focus",Zacks
Dec-14-18,Today's Research Reports on Trending Tickers: Bristol-Myers Squibb and Novartis,ACCESSWIRE
Dec-17-18,Roche's SMA Candidate Risdiplam Gets PRIME Designation in EU,Zacks
Dec-17-18,Incyte (INCY) Collaborates with Innovent for 3 Candidates,Zacks
Dec-18-18,Tilray shares soar on deal with Novartis. Here's what it ...,CNBC Videos
Dec-18-18,Tilray Jumps After Canadian Pot Stock Signs Deal With Novartis,Investor's Business Daily
Dec-18-18,"What's In Store for GE in 2019? & Tuesday's Trending Stocks: TLRY, JNJ, ORCL",Zacks
Dec-18-18,Why Tilray Is Jumping Today,Motley Fool
Dec-18-18,Tilray Partners with Novartis in Big Pharmas First Deal of Its Kind with Big Marijuana,Barrons.com
Dec-18-18,Tilray Shares Surge on Novartis Distribution Deal,TheStreet.com
Dec-18-18,Tilray Shares Jump On The Back Of Novartis Partnership,Benzinga
Dec-18-18,Puma Biotech's Nerlynx Ups Survival in Third-Line Breast Cancer,Zacks
Dec-18-18,Tilray partners with Novartis in Big Pharmas first deal of its kind with Big Marijuana,MarketWatch
Dec-18-18,Teva Reports Positive Top-Line Data for Migraine Candidate,Zacks
Dec-18-18,"Alkermes, Biogen Submit NDA to FDA for Multiple Sclerosis Drug",Zacks
Dec-18-18,Cannabis company Tilray shares jump 11% after announcing deal with Swiss drugmaker Novartis,CNBC
Dec-18-18,"J&J Okays $5B Stock Buyback Plan, Stock Remains Stressed",Zacks
Dec-19-18,Major pharma companies plan to raise drug prices in January: report,MarketWatch
Dec-19-18,Exclusive: Big Pharma returning to U.S. price hikes in January after pause,Reuters
Dec-19-18,Exclusive: Big Pharma returning to U.S. price hikes in January after pause,Reuters
Dec-19-18,Tilray shares surge after announcing $100 million deal with AB InBev to study cannabis-based beverages,CNBC
Dec-19-18,Aduro Stock Surges on STING Activator Deal With Eli Lilly,Zacks
Dec-19-18,Tilray Stock Up on Medical Cannabis Collaboration With Sandoz,Zacks
Dec-19-18,"Company News For Dec 19, 2018",Zacks
Dec-19-18,"Glaxo, Pfizer to Merge Consumer Health Units, Form New JV",Zacks
Dec-19-18,"Novartis, China's Gan & Lee push into insulin amid diabetes epidemic",Reuters
Dec-19-18,Novartis links with China's Gan & Lee in global insulin push,Reuters
Dec-20-18,U.S body says gene therapy may be more cost effective for spinal muscular atrophy,Reuters
Dec-20-18,"Commentary: GSK, Pfizer and GE shift away from diversification in latest round of health-care deals",CNBC
Dec-20-18,Novartis oncology boss Barrett makes quick exit,Reuters
Dec-20-18,"The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum",Benzinga
Dec-20-18,Is Tilray Stock a Must-Buy Following New Partnership?,InvestorPlace
Dec-20-18,Novartis appoints Susanne Schaffert to lead oncology business,Reuters
Dec-21-18,Why Gene Therapy Is More Cost Effective Than Biogen's Approved Drug,Investor's Business Daily
Dec-21-18,Novartis (NVS) Offers to Buy French Gene Therapy Manufacturer,Zacks
Dec-24-18,Jazz (JAZZ) Falls as Sleep Drug Gets Extended Review From FDA,Zacks
Dec-27-18,Teva Stock Rises on Patent Settlement With Neos Therapeutics,Zacks
Dec-27-18,"Forget J&J, Buy These 3 Big Drug Stocks Instead in 2019",Zacks
Dec-28-18,Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan,Zacks
Dec-31-18,Novartis (NVS) Benefits From New Drugs & Key Acquisitions,Zacks
Jan-03-19,Verily lines up $1 billion investment,American City Business Journals
Jan-03-19,Bristol-Myers' (BMY) Sprycel Gets FDA Nod for Label Expansion,Zacks
Jan-03-19,Ironwood/Allergan Settle Linzess Patent Litigation With Mylan,Zacks
Jan-03-19,Will Pfizer's (PFE) Stock Keep Up the Momentum in 2019?,Zacks
Jan-04-19,Tilray Gains More Than 200%: Is There More Scope for Growth?,Zacks
Jan-04-19,These Stocks Pop After FDA Expedites Review Of Gene-Editing Therapy,Investor's Business Daily
Jan-07-19,Cramer Remix: This chipmaker could have another bad quarterbut it's worth buying now,CNBC
Jan-07-19,Novartis CEO on chasing cures over profitable treatments,CNBC Videos
Jan-07-19,"Novartis CEO talks chasing cures over profitable treatments, says they will 'ultimately' be valued",CNBC
Jan-08-19,Novartis Stock Is Poised to Rise Another 15% From Here,TheStreet.com
Jan-08-19,"The Daily Biotech Pulse: Amgen Slashes Cholesterol Drug Device Prices By 60%, Takeda Completes Shire Purchase",Benzinga
Jan-09-19,Canopy Growth Moves to Key Resistance,Investopedia
Jan-09-19,Novartis' Crizanlizumab Gets Breakthrough Therapy Status,Zacks
Jan-10-19,Novartis migraine drug not cost effective - U.K. price watchdog,Reuters
Jan-11-19,NASH Space in Focus in 2019 as Firms Look to Diversify,Zacks
Jan-11-19,Will Tilrays Dealmaking Lift Tilray Stock in 2019?,InvestorPlace
Jan-11-19,Puma Biotech (PBYI) Down More Than 40% in 90 Days: Here's Why,Zacks
Jan-11-19,"Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet",Zacks
Jan-14-19,Tilray Shares Rally as Investor Plans Not to Sell Shares,Zacks
Jan-15-19,Here's How The Government Shutdown Will Affect These Medical Stocks,Investor's Business Daily
Jan-16-19,Adamis stock surges on release of EpiPen alternative,MarketWatch
Jan-16-19,Intrexon Signs Licensing Agreement with Next Green Wave,Zacks
Jan-16-19,"Tilray Teams Up With Authentic Brands, Stock Down on Sell-Off",Zacks
Jan-16-19,6 Reasons Why You Should Buy Eli Lilly (LLY) Stock in 2019,Zacks
Jan-17-19,NVS or AZN: Which Is the Better Value Stock Right Now?,Zacks
Jan-22-19,Alnylam &amp; Medison Partner to Market RNAi Products in Israel,Zacks
Jan-23-19,Why Tilray Stock Can Still Set Itself Apart From the Crowd,InvestorPlace
Jan-24-19,Is a Surprise in the Cards for Novartis (NVS) in Q4 Earnings?,Zacks
Jan-25-19,Novartis urges Britain to secure drug supplies before Brexit,Reuters
Jan-28-19,How Novartis Could Throw A Haymaker  And Slam Amgen's Sales,Investor's Business Daily
Jan-28-19,Amgen (AMGN) to Report Q4 Earnings: What's in the Cards?,Zacks
Jan-29-19,"Allergan (AGN) Q4 Earnings Beat Estimates, 2019 View Tepid",Zacks
Jan-30-19,"Despite Raising Prices, Big Pharma Is Selling Drugs for Less",The Wall Street Journal
Jan-30-19,"Novartis Slides On Earnings Lag, But Sees 10 New Blockbusters By 2020",Investor's Business Daily
Jan-30-19,Novartis CEO sees 'further conversation' on Sandoz future in 18 months,Reuters
Jan-30-19,Novartis 2019 growth outlook leaves investors wanting more,Reuters
Jan-30-19,"The Daily Biotech Pulse: Roche Scraps Alzheimer's Disease Trials, Amgen Issues Weak Guidance",Benzinga
Jan-30-19,A Cure for Cancer Next Year? The Stock Market Says Don't Believe the Hype,Motley Fool
Jan-30-19,Novartis: 4Q Earnings Snapshot,Associated Press
Jan-30-19,Novartis Misses Earnings and Sales Estimates in Q4,Zacks
Jan-30-19,[$$] Novartis's Bet on Higher-Value Drugs Pays Off,The Wall Street Journal
Jan-30-19,[$$] Novartis forecasts mid-single digit sales growth in 2019,Financial Times
Jan-30-19,"Novartis earnings narrowly miss expectations, shares down 2%",CNBC
Jan-31-19,"Novartis Posts Earnings, Revenue Miss",GuruFocus.com
Jan-31-19,"Novartis (NVS) Q4 Earnings Miss Estimates, Revenues Up Y/Y",Zacks
Feb-01-19,Mylan's Generic Version of Advair Diskus Wins FDA Approval,Zacks
Feb-01-19,Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance,Zacks
Feb-01-19,Gene Therapy: Novartis Under The Microscope With Novel Treatment,Investor's Business Daily
Feb-01-19,"Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY",Zacks
Feb-04-19,Teva Gains Positive CHMP Opinion for Migraine Drug Ajovy,Zacks
Feb-04-19,What's in the Cards for Glaxo (GSK) This Earnings Season?,Zacks
Feb-04-19,[$$] Novartis Backs Lutathera Pricing After Price-Gouging Accusations,The Wall Street Journal
Feb-05-19,Array Biopharma Inc (ARRY) Q2 2019 Earnings Conference Call Transcript,Motley Fool
Feb-05-19,Should You Buy Cronos Group Stock Right Now?,InvestorPlace
Feb-05-19,Novartis's Alcon eye-care unit to enter Swiss index after spin off,Reuters
Feb-05-19,Roche Submits sBLA to FDA for Label Expansion of Kadcyla,Zacks
Feb-05-19,"Gilead (GILD) Q4 Earnings Miss Estimates, Revenues Beat",Zacks
Feb-06-19,Novartis CEO says U.S. rebate plan will return cash to patients,Reuters
Feb-06-19,Novartis CEO says U.S. rebate plan will return cash to patients,Reuters
Feb-06-19,Glaxo Inks Deal With Merck KGaA to Co-Develop Cancer Candidate,Zacks
Feb-07-19,"Glaxo (GSK) Beats on Q4 Earnings, to Focus on Oncology in '19",Zacks
Feb-07-19,Novartis CEO lauds Trump administration plan to overhaul rebates,Reuters
Feb-08-19,Tilray (TLRY) to Report Q4 Earnings: What's in the Cards?,Zacks
Feb-08-19,Incyte Down as FDA Extends Review Period of Jakafi for GVHD,Zacks
Feb-08-19,"Ligand (LGND) Beats on Q4 Earnings &amp; Sales, Raises '19 View",Zacks
Feb-11-19,Is a Disappointment in Store for Incyte (INCY) Q4 Earnings?,Zacks
Feb-12-19,Aduro Initiates Dosing in Phase I Melanoma Study on ADU-S100,Zacks
Feb-13-19,Conatus (CNAT) Completes Enrollment in Phase II NASH Study,Zacks
Feb-13-19,Key Takeaways from Eli Lilly's (LLY) Q4 Earnings Report,Zacks
Feb-13-19,Clinigen agrees to buy U.S. rights to Novartis' cancer drug Proleukin,Reuters
Feb-13-19,"Top Research Reports for ExxonMobil, Merck & Danaher",Zacks
Feb-13-19,Clinigen agrees to buy U.S. rights to Novartis' cancer drug Proleukin,Reuters
Feb-14-19,"Incyte (INCY) Q4 Earnings Miss Estimates, Revenues Beat",Zacks
Feb-14-19,"The Zacks Analyst Blog Highlights: ExxonMobil, Merck, Danaher, Novartis and Expedia",Zacks
Feb-14-19,"The Daily Biotech Pulse: Vanda Q4 Results, Inovio Debt Offering, Caladrius Diabetes Drug Flunks Mid-Stage Trial",Benzinga
Feb-14-19,[$$] J&J and Novartis back cancer geneticists immunotherapy start-up,Financial Times
Feb-15-19,U.S. Medicare plans to track CAR-T cancer therapy outcomes,Reuters
Feb-15-19,Biogen Inc. -- Moody's announces completion of a periodic review of ratings of Biogen Inc.,Moody's
Feb-15-19,Medicare would cover CAR-T therapies under new CMS proposal,MarketWatch
Feb-19-19,Roche's (RHHBY) BLA for Lymphoma Drug Gets Priority Review,Zacks
Feb-20-19,AbbVie's RA Candidate Upadacitinib Gets FDA Priority Review,Zacks
Feb-20-19,"The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering",Benzinga
Feb-21-19,Biogen stock down 1.2% after downgrade by Stifel,MarketWatch
Feb-22-19,"Novartis gene therapy would be cost effective up to $900,000 -U.S. group",Reuters
Feb-22-19,"Novartis gene therapy is cost effective at up to $900,000 -U.S. group",Reuters
Feb-25-19,Why Investors Should Cash Out Of This Soaring Biotech Stock,Barrons.com
Feb-25-19,Novartis aims to pump up cardio business with Ionis deal,Reuters
Feb-25-19,Novartis In-Licenses Rights to Heart Candidate From Ionis,Zacks
Feb-25-19,Roche (RHHBY) to Acquire Spark Therapeutics for $4.8 Billion,Zacks
Feb-25-19,Roche bets $4.3 bln on Spark in gene therapy move,Reuters Videos
Feb-25-19,"Detailed Research: Economic Perspectives on Novartis AG, Proteostasis Therapeutics, Williams-Sonoma, Magna International, YRC Worldwide, and Delek Logistics Partners  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Feb-25-19,Novartis licenses rights to RNA-targeting cardio drug from Ionis,Reuters
Feb-26-19,Biotech ETFs Jump on Roche-Spark Deal,Zacks
Feb-26-19,Alkermes' (ALKS) and Biogen's NDA for BIIB098 Accepted by FDA,Zacks
Feb-27-19,"Trump ex-lawyer Cohen: drugmaker Novartis wanted him to lobby, he refused",Reuters
Feb-27-19,"Trump ex-lawyer Cohen: drugmaker Novartis wanted him to lobby, he refused",Reuters
Feb-27-19,"Trump's ex-lawyer Cohen: drugmaker Novartis wanted him to lobby, but he declined",Reuters
Feb-27-19,"Ophthotech's (OPHT) Q4 Loss Wider, Gene Therapy in Focus",Zacks
Feb-28-19,Aduro (ADRO) Q4 Earnings and Revenues Fall Shy of Estimates,Zacks
Feb-28-19,Novartis faces shareholder criticism over drug prices at AGM,Reuters
Feb-28-19,Novartis faces shareholder criticism over drug prices at AGM,Reuters
Mar-04-19,Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates,Benzinga
Mar-05-19,"FDA's Scott Gottlieb Resigns  What's Next For Biotech, Pharma?",Investor's Business Daily
Mar-05-19,Novartis has no plans to sell Sandoz - chairman,Reuters
Mar-05-19,"The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings",Benzinga
Mar-06-19,The Roche Merger Will Do Wonders for Spark Stock,InvestorPlace
Mar-06-19,"Ligand Sells Promacta Rights for $827M, Updates '19 View",Zacks
Mar-07-19,Gilead Reports Positive Data on HIV Drugs Biktarvy &amp; Descovy,Zacks
Mar-07-19,Alnylam Stock Down Despite Positive Phase III Givosiran Data,Zacks
Mar-08-19,Gilead Reports Positive Data on HIV Drugs Biktarvy &amp; Descovy,Zacks
Mar-08-19,Dutch join backlash at expensive drugs by making their own,Reuters
Mar-11-19,"Conatus' (CNAT) Q4 Earnings Top Estimates, Emricasan in Focus",Zacks
Mar-12-19,"[$$] Novartis, Volkswagen Focus on Improving Culture Following Compliance Setbacks",The Wall Street Journal
Mar-12-19,How This Looming Patent Battle Could Challenge Bristol-Celgene Deal,Investor's Business Daily
Mar-12-19,Allergan Announces FDA Acceptance of Migraine Candidate NDA,Zacks
Mar-12-19,Roche's (RHHBY) Tecentriq Gets FDA Approval for Breast Cancer,Zacks
Mar-14-19,Roche Receives EC Approval for Label Expansion of Hemlibra,Zacks
Mar-14-19,Blue Chip Drug Stocks Face 'Reckoning' on Future Downgrades,Investopedia
Mar-14-19,Novartis generics boss quits amid conjecture over business's future,Reuters
Mar-15-19,Roche Gets Approval for Label Expansion of MabThera in Europe,Zacks
Mar-15-19,"The Daily Biotech Pulse: KaryoPharm's Selinexor Review Delayed, FDA Accepts Adamis Opioid Overdose Drug NDA",Benzinga
Mar-18-19,Novartis' (NVS) Alcon Acquired PowerVision for $285 Million,Zacks
Mar-19-19,Tilray Earnings Impressive: More Reasons to Buy Marijuana ETFs,Zacks
Mar-19-19,3 Blue-Chip Stocks That Just Hit 52-Week Highs: Are They Buys?,Motley Fool
Mar-19-19,Tilray Inc (TLRY) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Mar-20-19,Major biotech landlord plants flag in East Bay with acquisition of Novartis site,American City Business Journals
Mar-20-19,Jazz Pharmaceuticals' Sleep Drug NDA Awaits FDA Decision,Zacks
Mar-20-19,Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan,Zacks
Mar-21-19,Is Biogen a Bad-News Buy Now?,Motley Fool
Mar-21-19,Cooper Companies' (COO) CooperVision Gains Momentum Globally,Zacks
Mar-22-19,Conatus (CNAT) Declines on Failure of NASH Fibrosis Study,Zacks
Mar-22-19,Biogen Stock Crashes on Termination of Alzheimer's Studies,Zacks
Mar-22-19,Conatus Shares Fall By More Than 50% After Midstage Study Shows NASH Candidate Lagged Placebo,Benzinga
Mar-22-19,Novartis says listing of Alcon eye care business expected on April 9,Reuters
Mar-22-19,Alcon Inc. -- Moody's assigns Baa2 issuer rating to Alcon; stable outlook,Moody's
Mar-25-19,Were Hedge Funds Right About Novartis AG  (NVS)?,Insider Monkey
Mar-25-19,"Health Care Digest: Genentech's tumor-agnostic cancer drug, Novartis' East Bay option and more",American City Business Journals
Mar-25-19,Alcon Inc. -- Moody's assigns Baa2 issuer rating to Alcon; stable outlook,Moody's
Mar-26-19,"The Daily Biotech Pulse: Japanese Cheer For AbbVie, Myokardia Offering, CytomX CFO Departs",Benzinga
Mar-27-19,Novartis (NVS) Receives FDA Approval for MS Drug Mayzent,Zacks
Mar-27-19,Jazz's Xyrem Follow-On Drug Succeeds in Phase III Study,Zacks
Mar-27-19,The Hits Just Keep Coming For Biogen As Rival Gains MS Drug Approval,Investor's Business Daily
Mar-27-19,Novartis MS drug wins FDA's blessing amid scrutiny of $88k annual price,Reuters
Mar-27-19,6 Gene Therapy M&A Targets On The Radar,Benzinga
Mar-27-19,"Novartis Multiple Sclerosis Drug With Price Tag of $88,000 Gets FDA Nod",TheStreet.com
Mar-27-19,FDA Approves Novartis Drug To Treat More Severe Form Of Multiple Sclerosis,Benzinga
Mar-27-19,"The Daily Biotech Pulse: FDA Nod For Novartis, Jazz Positive Late-Stage Data For Sleep Disorder Drug, Genfit IPO",Benzinga
Mar-27-19,"Novartis new MS drug Mayzent to be priced at $88,000 per year",Reuters
Mar-27-19,Novartis gets U.S. approval for new drug to treat multiple sclerosis,Reuters
Apr-01-19,Novartis (NVS) to Acquire Subsidiary of IFM Therapeutics,Zacks
Apr-01-19,Novartis Snags A $1.6 Billion Buy That Could Rival These Biotechs,Investor's Business Daily
Apr-01-19,Novartis Announces $1.575B Acquisition Of IFM Tre,Benzinga
Apr-01-19,"Swiss drugmaker Novartis must face doctor kickback suit, U.S. judge rules",Reuters
Apr-01-19,"Novartis must face doctor kickback lawsuit, U.S. judge rules",Reuters
Apr-01-19,"BMOs Got A Point About Teva Stock, But Are Investors Willing To Listen?",InvestorPlace
Apr-01-19,Novartis to pay $310 million for assets from inflammation specialist IFM,Reuters
Apr-01-19,Novartis scoops up IFM immunotherapy subsidiary for $310 million,American City Business Journals
Apr-02-19,Novartis Gets Approval for Psoriasis Drug Cosentyx in China,Zacks
Apr-02-19,Teva's Anti-CGRP Injection Ajovy Gets Approval in Europe,Zacks
Apr-02-19,"The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial",Benzinga
Apr-03-19,"Biogen SMA drug price, Novartis estimates for its treatment far too high: U.S. group",Reuters
Apr-03-19,"Biogen SMA drug price, Novartis estimates for its treatment far too high -U.S. group",Reuters
Apr-03-19,"Biogen SMA drug price, Novartis estimates for its treatment far too high -U.S. group",Reuters
Apr-03-19,"After inking lease with cancer-fighting company, this new East Bay biotech project is full",American City Business Journals
Apr-03-19,Allergan's AMD Drug Lowers Inflammation in Phase III Study,Zacks
Apr-03-19,Roche Extends Offer Period for Spark Therapeutics Acquisition,Zacks
Apr-03-19,"The Daily Biotech Pulse: Advaxis Offering, Roche's Spark Tender Offer Extended, Ascendis Earnings",Benzinga
Apr-03-19,Novartis's Alcon spinoff ousts Baer from Swiss benchmark SMI,Reuters
Apr-04-19,"Novartis, Amgen in dispute over migraine drug partnership",Reuters
Apr-04-19,Novartis Lawsuit Accuses Amgen Of Trying To Welsh On Migraine Deal,Investor's Business Daily
Apr-04-19,1 Biotech That Biogen Should Buy ... but Probably Won't,Motley Fool
Apr-04-19,"Top Analyst Reports for Amazon, 3M & Novartis",Zacks
Apr-04-19,3 Ways to Buy Into the Marijuana Boom Without the Risk,InvestorPlace
Apr-04-19,Novartis sues Amgen over migraine treatment Aimovig,Reuters
Apr-04-19,Achillion Meets Enrollment Target in Kidney Disease Studies,Zacks
Apr-04-19,Novartis Resubmits BLA to FDA for Biosimilar of Neulasta,Zacks
Apr-04-19,Novartis CEO's $50 Billion of Deals Was Just the First Act,Bloomberg
Apr-05-19,"Lawsuit over migraine deal could be good for Amgen, analysts say",MarketWatch
Apr-05-19,"Pharma Stock Roundup: NVS Inks Immunology Deal, PFE, TEVA Get Drug Approvals in EU",Zacks
Apr-05-19,Novartis &amp; Amgen in Legal Dispute Over Migraine Drug Aimovig,Zacks
Apr-05-19,Novartis Lawsuit Accuses Amgen Of Trying To Welsh On Migraine Deal,Investor's Business Daily
Apr-05-19,"The Zacks Analyst Blog Highlights: Amazon, 3M, Novartis, Schlumberger and ICICI",Zacks
Apr-05-19,"The Daily Biotech Pulse: Merrimack Pulls The Plug On Early-Stage Trial, Legal Headache For Novartis-Amgen Migraine Partnership",Benzinga
Apr-08-19,Eye-Care Leader Alcon Is About to Hit the Stock Market,Barrons.com
Apr-08-19,Corcept (CORT) Rides High on Cushing's Syndrome Drug Korlym,Zacks
Apr-08-19,"The Zacks Analyst Blog Highlights: Pfizer, Teva, Novartis, Merck and AstraZeneca",Zacks
Apr-08-19,"Lawsuit over migraine deal could be good for Amgen, analysts say",MarketWatch
Apr-09-19,What Happened in the Stock Market Today,Motley Fool
Apr-09-19,Here's Why Novartis Is Sliding Today,Motley Fool
Apr-09-19,Alcon Begins Trading After Spinoff From Novartis,TheStreet.com
Apr-09-19,Novartis News: NVS Stock Sinks Following Alcon Spin-Off,InvestorPlace
Apr-09-19,Alcon CEO on where the company is headed following spin-off from Novartis,CNBC Videos
Apr-09-19,Alcon Stock Is Trading Strongly in Its U.S. Debut After the Novartis Spinoff,Barrons.com
Apr-09-19,"The Daily Biotech Pulse: PhaseBio Gets Breakthrough Therapy Designation, FDA Shoots Down Zogenix Epilepsy Regulatory Filing",Benzinga
Apr-09-19,Alcon tops $28 billion market cap in decade's biggest Swiss stock deal,Reuters
Apr-09-19,Alcon tops $28 bln market cap in decade's biggest Swiss stock deal,Reuters
Apr-09-19,Alcon seen valued up to $25 billion in biggest Swiss stock deal in decade,Reuters
Apr-09-19,Top 5 Things to Know in The Market on Tuesday,Investing.com
Apr-09-19,FirstFT: Todays top stories,Financial Times
Apr-10-19,What Alcons Spinoff Can Teach Bausch Health,Barrons.com
Apr-10-19,5 Companies Paying High Dividend Yields,GuruFocus.com
Apr-10-19,Alcon Can See Clearly Now,GuruFocus.com
Apr-10-19,Amgen's (AMGN) Osteoporosis Drug Evenity Gets FDA Approval,Zacks
Apr-10-19,Second Time's The Charm For Amgen As FDA OKs Bone-Building Osteoporosis Drug,Benzinga
Apr-10-19,"Q1 Cannabis Wholesale Report: Best-Selling Brands And Products, Pharma, CBD And Interstate Commerce",Benzinga
Apr-11-19,Intercept Reports Additional Positive Data From NASH Study,Zacks
Apr-11-19,Heres the Real Problem with Altria Overpaying for CRON Stock,InvestorPlace
Apr-12-19,"Pharma Stock Roundup: AZN, MRK, GSK Get Regulatory Approvals, Sandoz Inks New Deal",Zacks
Apr-12-19,Ophthotech Gets Rights to Gene Therapy for BEST Disease,Zacks
Apr-15-19,Alnylam (ALNY) Reports Phase III ENVISION Data on Givosiran,Zacks
Apr-15-19,"Alcon Stock Is Back. The Eye-care Company Deserves a Long, Hard Look.",Barrons.com
Apr-16-19,Alnylam Initiates Phase III ILLUMINATE-B Study on Lumasiran,Zacks
Apr-16-19,Radius Health (RDUS) Rallies 33.4% YTD on Robust Tymlos Sales,Zacks
Apr-16-19,Marijuana ETF Down 9% in Past Month: Time to Enter the Space?,Zacks
Apr-16-19,Allergan Falls as Supreme Court Dismisses Restasis Litigation,Zacks
Apr-16-19,Novartis' (NVS) BLA for Ophthalmology Drug Accepted by FDA,Zacks
Apr-16-19,"The Daily Biotech Pulse: J&J Earnings, FDA Nod For Medicinova, Proteon To Explore Strategic Alternatives",Benzinga
Apr-17-19,Why A Highly Rated Biotech With A 54% Gain This Year Is Being Gutted,Investor's Business Daily
Apr-17-19,Here's Why Ionis Pharmaceuticals Slumped Today,Motley Fool
Apr-17-19,Why A Highly Rated Biotech With A 54% Gain This Year Is Being Gutted,Investor's Business Daily
Apr-17-19,"The Daily Biotech Pulse: Zolgensma Data, Roche Q1 Results, Brainsway IPO",Benzinga
Apr-18-19,Roche's (RHHBY) Q1 Sales Strong on Solid Demand for New Drugs,Zacks
Apr-22-19,A Second Baby Died In A Gene Therapy Study  Slugging This Biotech Stock,Investor's Business Daily
Apr-22-19,Pfizer Stock Suffers From an Underappreciated Drugs Pipeline,InvestorPlace
Apr-23-19,Medicare offers to partially raise payment for cancer CAR-Ts,Reuters
Apr-23-19,Health-care earnings: Medicare for all looms large,MarketWatch
Apr-24-19,Most Popular European Stocks of Top Investors,GuruFocus.com
Apr-24-19,Pharma Giant Eyes Better 2019 Profit And 3 New Blockbuster Hopefuls,Investor's Business Daily
Apr-24-19,(OFFICIAL)-Novartis mulling $1.5 mln-$5 mln price range for SMA gene therapy,Reuters
Apr-24-19,"Novartis Stock Is Up Because Its Profit Beat Forecasts, and the CEO Is Upbeat",Barrons.com
Apr-24-19,"Novartis (NVS) Q1 Earnings Beat Estimates, Revenues Up Y/Y",Zacks
Apr-24-19,"The Daily Biotech Pulse: FDA Greenlights AbbVie's Psoriasis Drug, Novartis Earnings, Patent Notification For MediciNova",Benzinga
Apr-24-19,Novartis shares rise as Swiss drugmaker lifts 2019 profit outlook,Reuters
Apr-24-19,Novartis: 1Q Earnings Snapshot,Associated Press
Apr-24-19,Novartis upgrades 2019 profit guidance on strong sales growth,Financial Times
Apr-24-19,"Novartis boosts 2019 outlook on rising Cosentyx, Entresto sales",Reuters
Apr-24-19,"StockBeat - Elliott Effect Lifts SAP, as Softbank Bets on Wirecard",Investing.com
Apr-25-19,"The Top 10 Biotechnology Companies (JNJ, ROG.VX)",Investopedia
Apr-26-19,Is This Highly-Anticipated Gene Therapy in Trouble?,Motley Fool
Apr-26-19,FDA approves biosimilar to Amgen's Enbrel,MarketWatch
Apr-26-19,Is a Beat in Store for Glaxo (GSK) This Earnings Season?,Zacks
Apr-29-19,Is a Beat in the Cards for Incyte (INCY) in Q1 Earnings?,Zacks
Apr-29-19,Why Novartis Earnings Provided A Bullish Signal For This Biotech Stock,Investor's Business Daily
Apr-29-19,"Cannabis stocks mixed with Aleafia falling after earnings, Canopy updates on NYC hemp plans",MarketWatch
Apr-30-19,"Incyte (INCY) Q1 Earnings &amp; Revenues Beat Estimates, Up Y/Y",Zacks
Apr-30-19,Can 'synthetic lethality' and deep experience propel this cancer-fighting biotech's $70M IPO?,American City Business Journals
May-02-19,PDL BioPharma (PDLI) to Post Q1 Earnings: What's in Store?,Zacks
May-02-19,What's The Buzz Around Novartis' Gene Therapy Zolgensma?,Benzinga
May-03-19,"Gilead (GILD) Earnings Beat, Revenues Miss Estimates in Q1",Zacks
May-03-19,"Ligand (LGND) Q1 Earnings &amp; Sales Fall Y/Y, Stock Down",Zacks
May-06-19,"Conatus' (CNAT) Earnings, Revenues Miss Estimates in Q1",Zacks
May-07-19,Novartis to release new gene therapy drug that could cost $2 million,CNBC Videos
May-07-19,"In The Search For Safety, Don't Miss The Swiss",Benzinga
May-08-19,Novartis buys Takeda's dry eye drug for $3.4 bln,Reuters
May-08-19,Novartis buys dry-eye drug Xiidra rights from Takeda for $3.4 billion,MarketWatch
May-08-19,Novartis buys Takeda's dry eye drug for $3.4 bln,Reuters
May-08-19,"Novartis confident of Zolgensma supply, calls $2 million price ""speculation""",Reuters
May-08-19,Aduro (ADRO) Q1 Earnings and Revenues Fall Shy of Estimates,Zacks
May-09-19,Novartis to Buy Takeda's Eye Drug in $5.3 Billion Deal,TheStreet.com
May-09-19,Novartiss $5.3 Billion Eye Disease Deal Adds Cash for Bigger Bets,Bloomberg
May-09-19,"Codexis Bags Novartis as Software Customer, Stays Course in First Quarter",Motley Fool
May-09-19,"The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stocks To Debut",Benzinga
May-09-19,"Stocks making the biggest moves premarket: Disney, Intel, Etsy, Fox Corp, Costco, Novartis & more",CNBC
May-09-19,Novartis buys dry eye drug from Takeda for up to $5.3 billion,Reuters
May-09-19,Novartis to Buy Takeda Eye Drug Assets in $5.3 Billion Deal,Bloomberg
May-09-19,Novartis buys dry eye drug from Takeda for up to $5.3 billion,Reuters
May-09-19,"Takeda sheds products, 485 jobs in deals worth $5.7B",American City Business Journals
May-10-19,Tilray (TLRY) to Report Q1 Earnings: What's in the Cards?,Zacks
May-10-19,"Pharma Stock Roundup: AGN, NVO Report Q1 Earnings, NVS to Buy Takeda's Eye Drug",Zacks
May-13-19,Teva Plummets Amid Massive Price Fixing Accusations; Other Generic Drugmakers Also Fall,Benzinga
May-13-19,Novartis vows to fight U.S. price-fixing claims against Sandoz unit,Reuters
May-13-19,Novartis vows to fight U.S. price-fixing claims against Sandoz unit,Reuters
May-14-19,Ionis Pharmaceuticals Is 40% of the Way There,Motley Fool
May-14-19,Generic Drugmakers Face Antitrust Suit Alleging Price Fixing,Zacks
May-14-19,Regeneron (REGN) Gets FDA Nod for Eylea Label Expansion,Zacks
May-15-19,Teva Hits Fibonacci Support on Concerns Over Lawsuit,Investopedia
May-15-19,"The Zacks Analyst Blog Highlights: Teva, Mylan, Novartis and Pfizer",Zacks
May-15-19,"Novartis gets approval to sell Kymriah in Japan for $306,000",Reuters
May-16-19,"Tilray Stock Is Red-Hot, But Its Fundamentally Flawed",InvestorPlace
May-16-19,Three Conservative Ways to Play Cannabis,MoneyShow
May-17-19,Dont Let the Great Q1 Numbers Fool You into Buying Tilray Stock,InvestorPlace
May-17-19,"Commentary: Novartis CEO: Gene therapy offers hope of cures in one treatment, but US needs new pricing and payment model",CNBC
May-17-19,"Commentary: Novartis CEO says gene therapies promise to upend US health system, pricing structure",CNBC
May-17-19,GSK and Novartis liniment marketing misled Australian consumers - court,Reuters
May-20-19,Adverum Up as FDA Lifts Hold on Cohort of Wet AMD Study,Zacks
May-20-19,Primary Drivers of the Chinese Economy,Investopedia
May-20-19,3 Ways to Buy Into the Marijuana Boom Without the Risk,InvestorPlace
May-20-19,Ligand Grants Preclinical Candidate Rights to UK-based Firm,Zacks
May-21-19,Cramer Remix: The cannabis stocks I'm eyeing,CNBC
May-21-19,Fix 'distortions' in health care system ahead of slate of drug launches: Novartis CEO,CNBC Videos
May-21-19,Fix 'distortions' in health care system ahead of slate of drug launches: Novartis CEO,CNBC
May-21-19,Novartis CEO calls for fixing 'distortions' in health care system ahead of slate of drug launches,CNBC Videos
May-21-19,Novartis CEO calls for fixing 'distortions' in health care system ahead of slate of drug launches,CNBC
May-21-19,These 3 Major Drug Manufacturers Are Strong Performers,GuruFocus.com
May-21-19,Novartis CEO says cannabis isn't a focus despite Tilray partnership,CNBC
May-21-19,Novartis CEO on single-payer health care: It is not the right move for America,CNBC Videos
May-22-19,Novartis CEO plans gene therapy price 'far lower' than $4 million to $5 million range,Reuters
May-22-19,Novartis CEO plans gene therapy price 'far lower' than $4 mln to $5 mln range,Reuters
May-22-19,Novartis Is a Difficult Stock to Trade or Own - Suggested Risk Point,TheStreet.com
May-22-19,"The Daily Biotech Pulse: Tocagen Tumbles, OncoSec Offering, Novartis Asthma Combo Drug Study",Benzinga
May-23-19,"Novartis Reports Data on Asthma Drug, Update from Annual Meet",Zacks
May-23-19,Tilray Stock Still Hasnt Bottomed,InvestorPlace
May-23-19,"Novartis CEO says data quality, lagging innovation crimp China M&A",Reuters
May-23-19,(Re)Focusing Big Pharma: Novartis CEO Vasant Narasimhan with Jim Cramer at Healthy Returns,CNBC Videos
May-23-19,"After IFM buy, Novartis looks to more early stage biotech M&A",American City Business Journals
May-23-19,Alphabet to Aid Pharma Giants Enhance Clinical Trial Process,Zacks
May-23-19,Novartis CEO sees chance to accelerate profit margin target,Reuters
May-23-19,Novartis has 25 blockbusters in the pipeline: CEO,Reuters
May-24-19,Approval of a Game-Changing Gene Therapy for SMA Delivers a Win for Novartis and Regenxbio,Motley Fool
May-24-19,Novartis $2 million gene therapy for rare disorder is world's most expensive drug,Reuters
May-24-19,"For Anderson family, an early bet on SMA gene therapy",Reuters
May-24-19,Novartis $2 mln gene therapy for rare disorder is world's most expensive drug,Reuters
May-24-19,"At $2M, priciest ever medicine treats fatal genetic disease",Associated Press
May-24-19,"For Anderson family, an early bet on SMA gene therapy",Reuters
May-24-19,Novartis Gene Therapy Crosses The $2 Million Mark  Will Others Follow?,Investor's Business Daily
May-24-19,Novartis gets FDA nod for advanced breast-cancer treatment,MarketWatch
May-24-19,Novartis' breast cancer treatment wins FDA approval,Reuters
May-24-19,"4 Top Stock Trades for Tuesday: ROKU, ADSK, SPLK, NVS",InvestorPlace
May-24-19,Novartis' breast cancer treatment wins FDA approval,Reuters
May-24-19,No Miracle Drug Should Cost $2.1 Million,Bloomberg
May-24-19,FDA approves Novartis gene therapy for rare genetic disorder,CNBC Videos
May-24-19,The Funded: One Bay Area biotech goes public while another files IPO plans,American City Business Journals
May-24-19,Biogen loses edge on blockbuster rare disease market with Novartis' FDA approval,American City Business Journals
May-28-19,FDA approves most expensive gene therapy ever  and here is its connection to Penn,American City Business Journals
May-28-19,Conatus Down More Than 60% in the Past 90 Days: Here's Why,Zacks
May-28-19,"Market Morning: Huawei Fumes, Volkswagen Feuds, Novartis Wins, Farage Threatens",Market Exclusive
May-28-19,A Closer Look at Vanguard Global ESG Select Stock,Morningstar
May-29-19,The Only 3 Marijuana Stocks You Need to Own,InvestorPlace
May-30-19,Save the Date: 11 Biotech Stocks to Put on Your Radar,Kiplinger
May-30-19,"PDL BioPharma's Royalties Help, Heavy Partner Reliance Hurts",Zacks
May-30-19,Bothered by the Price Tag of a $2.1 Million Drug? Read This Before Complaining Too Much,Motley Fool
May-30-19,"The Daily Biotech Pulse: Unity Biotech Licenses Anti-Aging Protein, Strong Results For Mereo's Brittle Bone Disease Drug",Benzinga
May-31-19,Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates,Benzinga
May-31-19,"Nationwide Children's invented 'the most expensive drug ever,' but the hospital didn't set the price",American City Business Journals
May-31-19,FDA approval of life-saving Nationwide Children's invention bodes well for ongoing gene therapy research,American City Business Journals
May-31-19,Biogen Reports Interim Phase III Data on Diroximel Fumarate,Zacks
May-31-19,Novartis (NVS) Reports Positive Phase III Data on Asthma Drug,Zacks
Jun-03-19,Novartis (NVS) Announces Various Data Presentations at ASCO,Zacks
Jun-03-19,Roche Presents Positive Data on Xolair &amp; Updates From ASCO,Zacks
Jun-03-19,Gilead Presents Data on CAR T Cell Therapy Candidate at ASCO,Zacks
Jun-03-19,Novartis Shows Growing Strength in Lung Cancer Innovation with New Capmatinib Investigational Data and Novel Canakinumab Clinical Trials,PR Newswire
Jun-05-19,Continued Smart M&A Moves Will Help Canopy Stock Break Out,InvestorPlace
Jun-06-19,Alnylam Completes Rolling NDA Submission to FDA for Givosiran,Zacks
Jun-06-19,Incyte Begins Phase III Study for Treatment of Duct Cancer,Zacks
Jun-06-19,Was ASCO Quieter for Big Drug/Biotech Stocks This Year?,Zacks
Jun-06-19,"The Daily Biotech Pulse: Takeda Pulls Plug On Amyloidosis Drug Trial, Chiasma Preps For Drug Launch With New CEO Appointment, Orchard Prices Offering",Benzinga
